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beneﬁcial effect could be detected on major adverse cardiac and cerebrovascular event
rates after MSCs infusion 6 months later.
Conclusions: Intracoronary infusion of MSCs does not improve clinical outcome and
cardiac function on MRI-derived parameters.
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Objectives: To investigate correlation between P2Y12 gene polymorphisms
(rs2046934, rs6787801, rs6798347 and rs6787801) and coronary heart disease.
Methods: 455 patients with coronary artery disease who were diagnosed by coronary
angiography or coronary artery CT angiography and 90 health control individuals
were enrolled in this study. The single nucleotide polymorphisms rs2046934,
rs6787801, rs6798347 and rs6787801 of P2Y12 gene were detected by MassARRAY
Time of Flight Mass Spectrometry. The genotypes and allele frequencies in the two
groups were compared.
Results: Genotypes and frequencies of P2Y12 gene polymorphisms rs2046934 in
coronary heart disease group and control group were as below: CC genotype 2.4%
vs. 4.4%, TT genotype 71.0% vs. 74.4%, CT genotype 26.6% vs. 21.2%; and C allele
frequencies were 2.4% vs. 4.4%, T allele frequencies were 84.3% vs. 85.0%. There
was no signiﬁcant difference between the two groups (P>0.05). Genotypes and
frequencies of P2Y12 gene polymorphisms rs6787801 in coronary heart disease
group and control group were: GG genotype 17.4% vs. 17.8%, AA genotype 36.9%
vs. 31.3%, GA genotype 45.7% vs. 51.1%; and G allele frequencies 40.2% vs.
43.3%; A allele frequencies 59.8% vs. 56.7%. There was no signiﬁcant difference
between these two groups (P>0.05). Genotypes and frequencies of P2Y12 gene
polymorphisms rs6798347 in coronary heart disease group and control group were as
below: AA genotype 9.1% vs. 6.7%, GG genotype 41.6% vs. 52.2%, AG genotype
49.3% vs. 41.1%; and A allele frequencies 29.9% vs. 27.2%, G allele frequencies
70.1% vs. 72.8%. There was no signiﬁcant difference between control group and
coronary heart disease group (P>0.05). Genotypes and frequencies of P2Y12 gene
polymorphisms rs6801273 in coronary heart disease group and control group were as
below: CC genotype 13.4% vs. 10.0%, TT genotype 42.6% vs. 50.0%, CT genotype
44.0% vs. 40.0%; and C allele frequencies 35.4% vs. 30.0%, T allele frequencies
64.6% vs. 70.0%. There was no signiﬁcant difference between the compared groups
(P>0.05).
Conclusions: Single Nucleotide Polymorphisms of P2Y12 gene polymorphisms in
rs2046934, rs6787801, rs6798347 and rs6798347 are not associated with coronary
heart disease.
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Objectives: Vascular endothelial injury caused by hypertension, hyperlipidemia,
hyperglycemia, and other risk factors often lead to vascular endothelial dysfunction,
intimal hyperplasia, chemotaxis of inﬂammatory cytokine secreting cells, and
accumulation of lipid deposits. As a result, coronary atheroscleroticplaque may
occur. Recent studies have suggested that similar to the myocardium and coronary
artery, epicardial adipose tissue (EAT), which is composed of adipocytes, macro-
phages, and monocytes, may produce numerous inﬂammatory cytokines. More
speciﬁcally, inﬂammatory cytokines secreted by EAT contribute to plaque insta-
bility. In this study we investigate how CHD and coronary atheroscleroticplaque
vulnerability are associated with epicardial adipose tissue volume (EATV) and the
inﬂammatory cytokines, matrix metalloproteinase-9 (MMP9) and leptin, derived
from EAT.
Methods: 260 patients were assessed for severity of coronary artery stenosis and
EATV by 64-slice dual-source cardiac computed tomography (CT) scans. These
patients were also screened to determine levels of adipokines in pericardial blood
and insulin resistance indices. Out of the 260 patients, 180 patients were conﬁrmed
to have CHD utilizing digital subtraction angiography (DSA), and the other 80
patients (40 of whom were assessed prior to valve replacement surgery) were
classiﬁed as non-CHD. The vascular remodeling indices and plaque vulnerability
parameters (lipid plaque volume, ﬁbrous plaque volume, and calciﬁed plaque vol-
ume) were measured in order to determine any signiﬁcant correlations with EATV.
Samples of EAT and thoracic adipose tissue (TAT) were collected during the cor-
onary artery bypass graft (CABG) surgery that 40 of the CHD patients received.
Samples were probed for mRNA level and protein level expression of leptin and
MMP9.
Results: (1) The EATVs were signiﬁcantly higher in the CHD group compared to
those of the NCHD group. (2) Subgroup analysis of the CHD patients demon-
strated that EATV in patients with positive remodeling was signiﬁcantly higher
(127.6342.00 cm3 vs. 95.4925.36 cm3) than that of the non-positiveJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Cremodeling group. Lipid plaque volume was positively correlated with EATV (P
¼ 0.04, r¼ 0.07); however, ﬁber plaque volume was negatively correlated with
EATV (P ¼ 0.0077, r¼ -0.06). (3) Logistic regression analysis indicated that
EATV is an independent risk factor for positive vascular remodeling. (4)
Compared to 40 NCHD patients, the 40 CHD patients who received CABG sur-
gery, presented higher levels of mRNA and protein expression of leptin and
MMP9 in EAT (P<0.01). However, there was no signiﬁcant difference (P> 0.05)
in mRNA and protein expression of leptin and MMP9 within the TAT of CHD and
NCHD patients. (5) In the CHD group, leptin and MMP9 levels in EAT and EATV
were positively correlated with lipid plaque volume and ﬁbrous plaque volume
(P<0.05).
Conclusions: Epicardial adipose tissue volume (EATV) and EAT-derived inﬂam-
matory cytokines are signiﬁcantly correlated with plaque vulnerability in coronary
heart disease (CHD). It has been determined that EATV is an independent risk factor
for both CHD and plaque vulnerability. Levels of inﬂammatory cytokines secreted by
EAT and TAT of CHD patients were found to be signiﬁcantly greater than those of
NCHD patients. Levels of inﬂammatory cytokines produced by EAT correlate with
EATVs; therefore, controlling levels EATV and inﬂammation may reduce plaque
vulnerability and decrease the risk of coronary heart disease.
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Objectives: The dynamic variance of plasma superoxide dismutase (SOD) and
malondialdehyde (MDA) in acute myocardial infarction after ischemic post-
conditioning has not been reported. The present study was to explore the effect of
ischemic postconditioning on plasma superoxide dismutase (SOD) and malondialde-
hyde (MDA) in acute ST-segment elevated myocardial infarction and clinical
signiﬁcance.
Methods: One hundred twenty patients [aged (6016) years; 86% male] of acute
myocardial infarction treated with emergency percutaneous coronary intervention
(PCI) were randomly assigned to a postconditioning or standard protocol. The plasma
SOD and MDA concentrations at 4, 8, 12, 16, 20, 24, 36, and 48 hours after the PCI
were compared respectively, and left ventricular ejection fraction (LVEF), left ven-
tricular end-diastolic volume index (LVEDVI), left ventricular end-systolic volume
index (LVESVI), region wall movement index (RWMI) after the operation for 2
weeks, and occurrence rate of cardiac events after the operation for a year were
compared between two groups.
Results:With similar time-to reperfusion [(16866) minutes in the postconditionging
group vs. (15660) minutes in the standard group, P¼0.56], the plasma SOD values
in the postconditionging group were higher [(115.333.7) ng/ml vs. (90.434.6) ng/
ml, P¼0.011] at 4 h, [(127.3.738.5) ng/ml vs. (95.532.1) ng/ml, P¼0.023] at 8 h,
[(129.243.5) ng/ml vs. (98.634.8) ng/ml, P¼0.021] at 12 h, [(118.337.7) ng/ml
vs. (95.432.6) ng/ml, P¼0.020] at 16 h, [(109.737.5) ng/ml vs. (83.532.8) ng/ml,
P¼0.033] at 20 h, [(117.233.5) ng/ml vs. (89.633.8) ng/ml, P¼0.017] at 24 h,
[(110.334.7) ng/ml vs. (88.434.8) ng/ml, P¼0.031] at 36 h, [(107.3.730.5) ng/ml
vs. (85.530.1) ng/ml, P¼0.043] at 48 h respectively than those in the standard
group. The MDA concentrations in the postconditionging group were lower
[(1.140.44) mmol/l vs. (2.680.66) mmol/l, P¼0.021] at 4 h, [(1.560.47) mmol/l
vs. (3.141.11) mmol/l, P¼0.031]at 8 h, [(1.870.77) mmol/l vs. (4.241.99) mmol/
l, P¼0.021] at 12 h, [(1.770.76) mmol/l vs. (4.011.84) mmol/l, P¼0.018] at 16 h,
[(1.650.65) mmol/l vs. (3.841.76) mmol/l, P¼0.023] at 20 h, [(1.450.47) mmol/l
vs. (3.231.33) mmol/l, P¼0.031] at 24 h, [(1.080.39) mmol/l vs. (2.290.96)
mmol/l, P¼0.044] at 36 h, [(0.780.37) mmol/l vs. (1.740.56) mmol/l, P¼0.043] at
48 h respectively than those in the standard group. After the operation for 2 weeks,
LVEF increased [(50.64.2) % vs. (47.55.3) %, P¼0.011], LVESVI [(31.35.1)
ml/m2 vs. (35.77.2) ml/m2, P¼0.008] and LVEDVI [(57.55.3) ml/m2 vs.
(61.85.9) ml/m2, P¼0.009] and RWMI [(1.510.46) vs. (1.730.52), P¼0.034]
decreased in the postconditionging group compared with the standard group respec-
tively. After the operation for a year, the occurrence rate of cardiac events in the
postconditionging group was signiﬁcantly lower (3.3% vs. 10.3%, P¼0.030] than that
in the standard group.
Conclusions: Ischemic postconditioning can increase plasma SOD concentration and
decrease MDA value between 4 hours and 48 hours after the PCI, and improve cardiac
function, left ventricular remodeling and prognosis in acute ST-segment elevated
myocardial infarction.
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